Europe Ambulatory Infusion Pumps Market, By Product Type (Devices, and Accessories and Consumables), Usage (Disposable and Reusable), Route of Administration (Subcutaneous, Intravenous and Epidural), Application (Emergency Medicine, General Anaesthesia, Pain Management, Oncology, Diabetes, Gastroenterology, Neonatology, Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings and Others), Distribution Channel (Direct Tender and Retail Sales) Industry Trends and Forecast to 2029.
Europe Ambulatory Infusion Pumps Market Analysis and Insights
Major factors driving the growth of this market are the increasing geriatric population, the expanding prevalence of chronic diseases such as cancer and diabetes, and positive patient outcomes in a less-expensive home setting. Ongoing technology developments and newer applications of ambulatory pumps in the home are driving an increase in their use. Recently, ambulatory pumps have been used to deliver various medications to treat various diseases and conditions, from diabetes to chronic pain. This mode of delivery typically involves using a needle or catheter under the skin to administer medications, blood products, nutrition, or hydrating solutions via the IV, subcutaneous, epidural/intrathecal, percutaneous, intrawound, intrahepatic, or other parenteral routes.
The main factors that may hamper the market's growth are the high cost associated with ambulatory infusion pump systems.
The ambulatory infusion pumps market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
Data Bridge Market Research analyses that ambulatory infusion pumps market will grow at a CAGR of 9.5% during the forecast period of 2022 to 2029.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customisable to 2019-2015)
|
|
Quantitative Units
|
Revenue in USD Million, Pricing in USD
|
|
Segments Covered
|
By Product Type (Devices, and Accessories and Consumables), Usage (Disposable and Reusable), Route of Administration (Subcutaneous, Intravenous and Epidural), Application (Emergency Medicine, General Anaesthesia, Pain Management, Oncology, Diabetes, Gastroenterology, Neonatology, Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings and Others), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Rest of Europe
|
|
Market Players Covered
|
B. Braun Melsungen AG, Baxter, Moog, Inc., WalkMed, KORU Medical Systems, Intra Pump Infusion Systems., AVNS., ICU Medical, Inc., Eitan Medical, Fresenius Kabi (a subsidiary of Fresenius SE & Co. KGaA), Medtronic, Micrel Medical Devices, Ace-medical, among others.
|
Market Definition
A medical device that delivers fluids, such as nutrients and medications, into a patient’s body in controlled amounts. Infusion pumps are in widespread use in clinical settings such as hospitals, nursing homes, and in the home. An infusion pump is operated by a trained user, who programs the rate and duration of fluid delivery through a built-in software interface. Infusion pumps offer significant advantages over manual administration of fluids, including the ability to deliver fluids in very small volumes, and the ability to deliver fluids at precisely programmed rates or automated intervals. They can deliver nutrients or medications, such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers.
Infusion pump systems are an active treatment aiming to monitor the medication in small amounts in different settings such as hospitals, clinics, and even at home. It is used to supply a controlled amount of drugs very slowly into the bloodstream over a period of time. It can be used in stationary and mobile environments to administer pain medication, antibiotics, chemotherapy medication, and hydrating fluids.
Ambulatory Infusion Pump Market Dynamics
Drivers
- Increase in the geriatric population
With the increasing age comes a reciprocal increase in the elderly patients admitted to the hospitals due to the rising prevalence of the chronic disease. Age is a severe risk factor for any disease progression, since age is an essential parameter that affects fundamental biological mechanisms. Chronic diseases such as cancer enormously occur in the geriatric population, with nearly 60% of cancers occurring in the geriatric populace age group older than 65. Cancer disease is very challenging in the geriatric populace, as due to age factors geriatric populace is already suffering from numerous health-related problems. This indicates the growing demand of infusion pumps from the geriatric populace.
With the ability to deliver fluids in a very small amount in a controlled environment directly to the bloodstream, the demand for infusion pump systems is rising in the healthcare system globally. The increasing need for proper treatment proportionally surges the demand for care, services, and technologies for preventing and treating conditions, including cardiovascular diseases, stroke, cancer, chronic respiratory diseases, and other complications. With the increasing age and rising prevalence of chronic diseases, the demand for early diagnosis of the diseases are also increasing. The demand for care, services, and technologies is rising to treat chronic conditions in old age. Thus, the increase in the geriatric population is expected to drive the growth of the ambulatory infusion pumps market.
- Growing technological advancements in infusion pumps system
The contribution of technological advancements in healthcare and clinical services is being taken out of the confines and made it more accessible. Technological developments in infusion pump results in prevention of medication errors and reduction of patient harm. These advancements result in improving clinical outcomes with a patient monitoring technology to inform and guide clinicians' treatment decisions.
Technology diversifies and plays a role in almost all processes in the healthcare industry, such as the possibility of medication errors exists due to an increase in disease burden, patient registration for data management, and laboratory testing for self-care equipment, making it the next boosting factor for infusion pump systems, accessories, and software market. The innovation and advancement in technology have upgraded the infusion pump systems in all prospects, including advanced features like increased accuracy, mobility, flexibility, and different choice smooth automatic multi-channel. The advancement in technologies brings many advantages towards the efficiency of procedures leading to increased patient safety. Hence, growing technological advancements in infusion pump systems are expected to drive the ambulatory infusion pumps market.
Opportunities
- Increasing incidences of chronic diseases
The high prevalence of chronic diseases due to the rapidly increasing population and infections can be seen globally. Individual risk factors, environmental factors, lack of physical activities, and human lifestyles are the major factors that further contribute to rising incidences of diseases. The evaluation of disorders will further lead to high demand for clinical studies through different routes of administration of drug deliveries in the human body. The rise in the incidence of diseases such as cardiovascular and cancer has led to an increase in demand for intravenous infusion pump devices.
Restraints/Challenges
- Side-effects associated with infusion pumps system
The rising use of infusion pumps with the advancement in technology has become standard practice in hospitals to administer critical fluids to patients. However, there are still limited research studies for reducing errors and improving infusion pump use that lead to adverse events in the system. The various problems associated with it can be software errors or human errors.
The side –effects associated with infusion pump systems include Software problems, Inadequate user interface design, Broken components, Alarm errors, Battery failures, and Charring, or shocks.
- High cost linked with infusion pumps system
Patients with chronic diseases such as acute respiratory distress syndrome must have long hospitalizations with regular monetarization and ventilation usage, leading to a significant amount of healthcare resources, due to which most patients who cannot afford long-term stay and get discharged in the initial stages of treatment. But this increases the possibilities and susceptibilities for new complications in infections which demands additional healthcare resources and treatment.
The high cost of the treatment is due to the various checkpoints of the treatment along with the use of high-tech modalities to perform such treatment procedures. The hospital care further adds to the cost of the infusion pump interventions. As the cost of innovative and advanced infusion pumps is high, the cost of the treatment proportionally gets escalated, due to which high cost associated with the use of the infusion pumps systems is expected to restrain the ambulatory infusion pumps market.
Recent Developments
- In March 2022, Fresenius Kabi, announced that the company has acquired Ivenix, Inc., a medical technology company specializing in advanced technologies infusion system. This help in accelerating strategic growth in biopharmaceuticals and Medtech that results in expanding the large and growing infusion therapy market.
- In February 2022, ICU Medical, Inc., Plum 360 Infusion System once again receives best in KLAS honour as top-performing smart pump EMR-integrated. This Best in KLAS designation is based on feedback from thousands of healthcare providers throughout the United States and Canada and results from in depth side-by-side comparisons of IV smart pump performance in multiple categories, including culture, loyalty, operations, product, relationship, and value.
Ambulatory Infusion Pumps Market Segmentation
The ambulatory infusion pumps market is categorized into six notable segments which are based on product type, usage, route of administration, application, end user and distribution channel. The growth among segments helps you analyses niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Product Type
- Devices
- Accessories & Consumables
On the basis of product type, the ambulatory infusion pumps market is segmented into devices, accessories and consumables.
Usage
- Disposable
- Reusable
On the basis of usage, the ambulatory infusion pumps market is segmented into disposable and reusable.
Route of Administration
- Intravenous
- Subcutaneous
- Epidural
On the basis of route of administration, the ambulatory infusion pumps market is segmented into intravenous, subcutaneous, and epidural.
Application
- Pain Management
- Diabetes
- Oncology
- Neonatology
- Gastroenterology
- General Anaesthesia
- Emergency Medicine
- Others
On the basis of application, the ambulatory infusion pumps market is segmented into pain management, diabetes, oncology, neonatology, gastroenterology, general anaesthesia, emergency medicine, and others.
End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- others
On the basis of end-user, the ambulatory infusion pumps market is segmented into hospitals, home care settings, ambulatory surgical centers, specialty clinics, and others.
Distribution Channel
- Direct Tender
- Retail Sales
On the basis of distribution channels, the ambulatory infusion pumps market is segmented into direct tender and retail sales.
Ambulatory Infusion Pumps Regional Analysis/Insights
The ambulatory infusion pumps is analysed and market size insights and trends are provided by product type, usage, route of administration, application, end user and distribution channel as referenced above.
The countries covered in the ambulatory infusion pumps report are Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, and Rest of Europe.
The Germany is expected to dominate the ambulatory infusion pumps market due to the rising healthcare infrastructure and strategic collaborations among key market players in the region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Ambulatory Infusion Pumps Share Analysis
The ambulatory infusion pumps competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on ambulatory infusion pumps market.
Some of the prominent players operating in this market are B. Braun Melsungen AG, Baxter, Moog, Inc., WalkMed, KORU Medical Systems, Intra Pump Infusion Systems., AVNS., ICU Medical, Inc., Eitan Medical, Fresenius Kabi (a subsidiary of Fresenius SE & Co. KGaA), Medtronic, Micrel Medical Devices, Ace-medical, among others.
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Europe vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
SKU-